Claret Asset Management’s ProMIS Neurosciences PMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Buy |
+11,330
| New | +$5K | ﹤0.01% | 436 |
|
|
2025
Q1 | – | Sell |
-11,330
| Closed | -$11K | – | 302 |
|
|
2024
Q4 | $11K | Hold |
11,330
| – | – | ﹤0.01% | 306 |
|
|
2024
Q3 | $14K | Buy |
11,330
+500
| +5% | +$618 | ﹤0.01% | 335 |
|
|
2024
Q2 | $16K | Hold |
10,830
| – | – | ﹤0.01% | 251 |
|
|
2024
Q1 | $21K | Hold |
10,830
| – | – | ﹤0.01% | 212 |
|
|
2023
Q4 | $12K | Hold |
10,830
| – | – | ﹤0.01% | 191 |
|
|
2023
Q3 | $22K | Sell |
10,830
-1,500
| -12% | -$3.05K | ﹤0.01% | 156 |
|
|
2023
Q2 | $47K | Hold |
12,330
| – | – | 0.01% | 156 |
|
|
2023
Q1 | $59K | Hold |
12,330
| – | – | 0.01% | 152 |
|
|
2022
Q4 | $55K | Hold |
12,330
| – | – | 0.01% | 147 |
|
|
2022
Q3 | $75K | Buy |
+12,330
| New | +$75K | 0.02% | 146 |
|